Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes. By combining deep expertise in clinical trials with cutting-edge AI, we empower research teams and study sponsors to expand and expedite access to novel therapeutics for patients in need. The company has headquarters in Cambridge, Massachusetts, […]
DeepSight™ Technology is revolutionizing diagnostic medical imaging by taking the safest, fastest, most affordable, and most accessible imaging modality and delivering a quantum leap in performance.
Headquartered in South San Francisco, California, Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies.
Allay Therapeutics is pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation for patients and physicians.
Allay Therapeutics Read More »
Elegen is bringing unique insights and technical innovation to create high-quality synthetic DNA faster, catalyzing the next revolution in the life sciences. The company is led by seasoned leaders with decades of experience developing novel and scalable approaches in molecular biology, chemistry and microfluidics. Elegen uses a proprietary microfluidics approach to build longer, higher-quality DNA
Headquartered in Seattle and Singapore, Callio Therapeutics is focused on realising the promise of multi-payload antibody-drug conjugates to transform cancer patient outcomes. The company is developing next-generation, multi-payload antibody-drug conjugates (ADCs) that feature differentiated payload and linker technologies that enable targeted delivery of multi agents to tumor cells to maximize therapeutic benefit. Callio Therapeutics’ lead
Callio Therapeutics Read More »
Dedicated to a ‘more human’ way to deliver radiation therapy, Leo Cancer Care emphasises on patient comfort and efficient treatment delivery, built on research showing the clinical benefits of upright positioning and patient rotation.
Leader in AI-enabled digital stethoscopes to aid early detection of cardiopulmonary diseases, Eko Health’s FDA-approved AI digital stethoscope, empowers healthcare professionals to swiftly and accurately detect and diagnose heart conditions.
Automera is an early-stage company specialising in autophagy-based protein degradation therapies, leveraging quantum chemistry and AI tools for drug development. Its AUTAC platform has potential in cancer and other diseases, with oncology as its initial focus.
ArteraAI is a leading precision medicine company developing AI tests to personalize cancer therapy. ArteraAI offers an AI-enabled test that is the first of its kind to provide both predictive and prognostic results for patients with localized prostate cancer.
Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.
